Medtronic InterStim® Therapy for Urinary Control
Indications:
InterStim Therapy for Urinary Control is indicated for the treatment of urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments.
Contraindications:
Patients are contraindicated for implant of the InterStim System if they have not demonstrated an appropriate response to test stimulation or are unable to operate the neurostimulator. Also, diathermy (e.g., shortwave diathermy, microwave diathermy or therapeutic ultrasound diathermy) is contraindicated because diathermy's energy can be transferred through the implanted system (or any of the separate implanted components), which can cause tissue damage and can result in severe injury or death. Diathermy can damage parts of the neurostimulation system.
Precautions/Adverse Events:
Warning: This therapy is not intended for patients with mechanical obstruction such as benign prostatic hypertrophy, cancer, or urethral stricture. |
Safety and effectiveness have not been established for: bilateral stimulation, patients with neurological disease origins such as multiple sclerosis, pregnancy and delivery, or for pediatric use under the age of 16. System may be affected by or adversely affect cardiac pacemakers or therapies, cardioverter defibrillators, electrocautery, external defibrillators, ultrasonic equipment, radiation therapy, magnetic resonance imaging (MRI), theft detectors and screening devices. Adverse events related to the therapy, device, or procedure can include: pain at the implant sites, lead migration, infection or skin irritation, technical or device problems, transient electric shock, adverse change in bowel or voiding function, numbness, nerve injury, seroma at the neurostimulator site, change in menstrual cycle, and undesirable stimulation or sensations.
CAUTION: Federal law (USA) restricts this device to sale by or on the order of a physician.
Page Sponsored by Medtronic Urology
overactive bladder therapy, OAB treatment, Interstim treatment, got to go therapy, urgency treatment, urinary retention treatment, nerve stimulator
Medtronic InterStim® Therapy for Urinary Control
Medtronic InterStim Therapy for Urinary Control has been shown in clinical studies to successfully treat certain bladder control problems in many patients for whom other treatments were unsuccessful.
InterStim Therapy is indicated for the treatment of non-obstructive urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments.
InterStim Therapy uses a small device to send mild electrical pulses to the sacral nerve, which influences the bladder and surrounding muscles that manage urinary function.
Physicians and patients can assess the effectiveness of the therapy through a minimally invasive, in-office screening test before committing to implantation of the entire system.
After a successful screening test, the chronic lead is placed in the S2, S3 or S4 foramen using a minimally invasive procedure. An extension (if applicable) connects the lead to the neurostimulator, which is typically implanted in the upper buttocks, below the beltline. Abdominal placement is also an option with Model 3023.
More than 40,000 patients have received InterStim Therapy worldwide since FDA approval in 1997.
For more information about InterStim Therapy, visit Medtronic.
For information about InterStim Therapy educational opportunities, visit Medtronic.
